FDA Guidance for Industry: An Acceptable Circular of Information for the Use of Human Blood and Blood Components

Title:
FDA Guidance for Industry: An Acceptable Circular of Information for the Use of Human Blood and Blood Components
Origin/Publisher:

Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/

Document Type:
Guidance for Industry
Content:
the Circular will assist you in complying with labeling requirements under 21 CFR 606.122 (§ 606.122).

Go back